MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from share
issuance
$2,197K
Net cash provided by
financing activities
$927K
Canceled cashflow
$1,270K
Net
increase/(decrease) in cash, cash...
-$3,700K
Canceled cashflow
$927K
Stock-based compensation
expense
$2,279K
Depreciation and
amortization
$59K
Prepaid expenses and
other current assets
-$51K
Trade and other
payables
$44K
Unrealized loss on foreign
currency remeasurement
-$24K
Share repurchase
$1,179K
Share issuance costs
$91K
Net cash used in
operating activities
-$4,622K
Canceled cashflow
$2,457K
Net cash used in
investing activities
-$4K
Net loss
-$6,521K
R&d tax incentive
$558K
Purchase of property,
plant and equipment
$4K
Back
Back
Cash Flow
source: myfinsight.com
Incannex Healthcare Inc. (IXHL)
Incannex Healthcare Inc. (IXHL)